The drug monographs in AusDI are a suite of independently authored, clinically relevant monographs written at a single ingredient or class level covering both Therapeutic Goods Administration (TGA) approved and off-label indications.
Each individual monograph covers the basic information which is applicable to that ingredient when used for a specific area of effect (e.g. systemic).
Information that is unique for a specific dosage form of the base ingredient is then included under that specific dosage form heading.
Each monograph contains the following information
1. Therapeutic Class
4. Precautions to Consider
5. Side/Adverse Effects
7. Counselling information for the healthcare professional
8. General Dosing Information
9. Revision date